According to Royalty Pharma's latest financial reports and stock price the company's current Operating Margin is 27.89%. At the end of 2022 the company had an Operating Margin of 10.28%.
Year | Operating Margin | Change |
---|---|---|
2022 | 10.28% | -81.03% |
2021 | 54.21% | -32.41% |
2020 | 80.21% | -40.88% |
2019 | 135.67% | 60.43% |
2018 | 84.57% | 0.6% |
2017 | 84.06% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | 15.60% | -44.07% | ๐บ๐ธ USA |
Eli Lilly LLY | 24.66% | -11.58% | ๐บ๐ธ USA |
ANI Pharmaceuticals ANIP | -9.64% | -134.56% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.